EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 25 May 2022

The time is now: How to restore Europe’s leading position in pharma innovation

Hubertus von Baumbach (Boehringer Ingelheim) for POLITICO

Recent crises have highlighted the critical need for Europe to secure and strengthen its position as leader in medical innovation. As the European Commission works on the review of the Pharmaceutical Regulation, we need to ensure Europe has the right environment to bring the next generation of treatments to patients. The challenge for the coming decades is not if medical innovation will happen but where it will happen.

This article is part of a series explaining that where innovation happens matters for patients, health care systems, the research community, jobs and the economy.

Read more

News

RETHINKING Alzheimer’s disease project, calling for change in Alzheimer’s care, kicks off!
24 May 2022

Now is the time to rethink Alzheimer’s disease to improve Alzheimer’s disease care pathway and the lives of people living... Read more

Innovative Clinical Trials

"Patients with unmet needs are longing for innovative treatments to be approved. Especially rare disease patients, where only 5-6% have approved treatments, need a new strategy to speed up research and provide new opportunities to access innovative drugs. Complex clinical trials can be the change that patients want to see".
Claas Röhl, chairman of NF Patients United

Better fit research into patients' lives
"New trials enable participants to continue with their day-to-day lives with minimal disruption", says Jenny Camaradou,... Read more

Unlocking new benefits for patients & medical research
"Ambitions are high, and it’s not always easy, but #WeWontRest until we get to the innovative design that improves and... Read more

EFPIA Conference | Save the Date | Brussels & Online

Recently published

Shortening the WAIT - Patient Access to Medicines in Europe
06 April 2022 (News & Events)

Disparities in the time it takes for patients to access new medicines in different EU Member States are increasing. Read more

New proposals from the research-based pharmaceutical industry should reduce inequalities in...
11 April 2022 (News & Events)

Europe's pharmaceutical sector is stepping up measures to help deliver faster, more equitable access to medicines for... Read more

Are medicines affordable for health systems? The myths, the facts and the way forward
07 April 2022 (News & Events)

Pharmaceutical expenditure has been stable as a share of total healthcare expenditure in all European countries included... Read more

What we are reading

Early signs support revolutionary potential of EU clinical trials regulation
On 23 May 2022 (ulises-project.eu)

Featuring Silvia Garcia, Senior Manager, Regulatory, Drug Development and Manufacturing at EFPIA. Read more

Working At The Speed Of Science And Why You Should Be Excited
On 13 May 2022 (IFLS)

During the COVID-19 pandemic, pharmaceutical companies and researchers around the world raced to develop a vaccine. Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu